Analysen von Emmanuel Papadakis

23.01.18 Sanofi Underweight Barclays Capital
22.01.18 Bayer Underweight Barclays Capital
03.01.18 Bayer Underweight Barclays Capital
06.12.17 Bayer Underweight Barclays Capital
17.11.17 Bayer Underweight Barclays Capital
15.11.17 Novo Nordisk Underweight Barclays Capital
07.11.17 Bayer Underweight Barclays Capital
06.11.17 Bayer Underweight Barclays Capital
25.10.17 Novartis Underweight Barclays Capital
10.08.17 Novo Nordisk Underweight Barclays Capital
02.06.17 Novartis Underweight Barclays Capital
08.05.17 Sanofi Underweight Barclays Capital
08.03.17 Novo Nordisk Underweight Barclays Capital
08.03.17 Sanofi Underweight Barclays Capital